GUSTAVO SALGUERO

Curexsys is a Göttingen-based biotechnology company specializing in the development of a proprietary platform for the industrial-scale production and purification of exosomes. Founded by Dr. Jens Gruber and Dr. Gustavo Salguero, the company addresses the critical manufacturing bottlenecks in the exosome field, such as purity and scalability, to enable clinical applications. Curexsys utilizes a unique non-targeted purification process that preserves the biological activity of exosomes while ensuring high yield, primarily focusing on mesenchymal stem cell (MSC)-derived products. The company has established a significant strategic partnership with Sartorius to co-develop downstream processing technologies. Curexsys aims to lead the transition from cell-based to cell-free regenerative therapies for inflammatory and age-related conditions.